3 days ago
Vor Biopharma (VOR) Gets a Hold from Robert W. Baird
Robert W. Baird analyst Jack Allen maintained a Hold rating on Vor Biopharma (VOR – Research Report) today and set a price target of $1.00. The company's shares closed today at $0.89.
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Allen covers the Healthcare sector, focusing on stocks such as Vor Biopharma, Bluebird Bio, and Fate Therapeutics. According to TipRanks, Allen has an average return of -21.2% and a 27.08% success rate on recommended stocks.
The word on The Street in general, suggests a Hold analyst consensus rating for Vor Biopharma with a $0.32 average price target, which is a -64.04% downside from current levels. In a report released today, Wedbush also maintained a Hold rating on the stock with a $0.40 price target.
